We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
-3.03%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$8.84B
AUM Growth
-$870M
Cap. Flow
-$334M
Cap. Flow %
-3.78%
Top 10 Hldgs %
9.41%
Holding
997
New
62
Increased
315
Reduced
362
Closed
68

Top Buys

Rank Stock Value
1
KD icon
Kyndryl
KD
+$22.1M
2
CRI icon
Carter's
CRI
+$21.6M
3
ENOV icon
Enovis
ENOV
+$19.7M
4
M icon
Macy's
M
+$18.4M
5
SPNS
Sapiens International
SPNS
+$18.3M

Top Sells

Rank Stock Value
1
VIVO
Meridian Bioscience Inc
VIVO
+$48.8M
2
SPB icon
Spectrum Brands
SPB
+$27.6M
3
HUN icon
Huntsman Corp
HUN
+$22.1M
4
EAF icon
GrafTech
EAF
+$17.5M
5
VNT icon
Vontier
VNT
+$17.5M

Sector Composition

Rank Sector Weight
1 Industrials 27.25%
2 Technology 17.95%
3 Consumer Discretionary 13.92%
4 Financials 13.49%
5 Materials 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GASS icon
801
StealthGas
GASS
$326M
$588K 0.01%
229,664
MTTR
802
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$568K 0.01%
+150,000
New +$661K
SAIA icon
803
Saia
SAIA
$10.5B
$560K 0.01%
2,945
VRTV
804
DELISTED
VERITIV CORPORATION
VRTV
$554K 0.01%
+5,662
New +$673K
SSTK icon
805
Shutterstock
SSTK
$209M
$553K 0.01%
+11,022
New +$633K
INDI icon
806
indie Semiconductor
INDI
$636M
$549K 0.01%
+75,000
New +$555K
VIR icon
807
Vir Biotechnology
VIR
$1.46B
$546K 0.01%
+28,308
New +$720K
IAG icon
808
IAMGOLD
IAG
$8.05B
$535K 0.01%
500,000
CCBG icon
809
Capital City Bank Group
CCBG
$897M
$528K 0.01%
16,988
AIN icon
810
Albany International
AIN
$2.09B
$526K 0.01%
+6,676
New +$574K
CVT
811
DELISTED
Cvent Holding Corp. Common Stock
CVT
$525K 0.01%
100,000
ALKT icon
812
Alkami Technology
ALKT
$1.96B
$524K 0.01%
34,800
+10,700
+44% +$156K
DCOM icon
813
Dime Commercial Bancshares
DCOM
$1.79B
$523K 0.01%
+17,876
New +$569K
SHOO icon
814
Steven Madden
SHOO
$3.17B
$523K 0.01%
+19,608
New +$617K
GMS
815
DELISTED
GMS Inc
GMS
$511K 0.01%
+12,775
New +$611K
BMI icon
816
Badger Meter
BMI
$3.87B
$507K 0.01%
+5,489
New +$509K
PRG icon
817
PROG Holdings
PRG
$1.71B
$505K 0.01%
+33,701
New +$633K
WPRT
818
Westport Fuel Systems
WPRT
$31.9M
$504K 0.01%
57,849
-5,920
-9% -$65.6K
BLFS icon
819
BioLife Solutions
BLFS
$1.54B
$491K 0.01%
21,600
-200
-0.9% -$4.28K
REPX icon
820
Riley Exploration Permian
REPX
$728M
$490K 0.01%
+25,830
New +$633K
NOA
821
North American Construction
NOA
$357M
$479K 0.01%
50,000
BAND
822
Bandwidth Inc
BAND
$1.18B
$476K 0.01%
40,000
JELD icon
823
JELD-WEN Holding
JELD
$110M
$473K 0.01%
54,039
-496,900
-90% -$6.51M
CPF icon
824
Central Pacific Financial
CPF
$1.02B
$470K 0.01%
+22,739
New +$513K
KBAL
825
DELISTED
Kimball International
KBAL
$469K 0.01%
74,600

Similar funds

Royce & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Royce & Associates held 997 positions worth $8.84B, down 9% from $9.71B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Royce & Associates withdrew a net $334M in Q3 2022, closing 68 positions and reducing 362 holdings. Its most notable exit was Avalara, Inc., an estimated $17.4M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Royce & Associates opened a new position in Kyndryl worth $17.6M.

  • Royce & Associates's largest Q3 2022 buy was Kyndryl: 2,126,158 shares worth $17.6M.
  • Royce & Associates added most to Carter's in Q3 2022, an estimated $21.6M increase.
  • Royce & Associates's biggest Q3 2022 reduction was Meridian Bioscience Inc, cutting an estimated $48.8M.
  • Royce & Associates fully exited Avalara, Inc. in Q3 2022, selling an estimated $17.4M.
  • Royce & Associates's ten largest holdings make up 9.4% of its $8.84B portfolio in Q3 2022.
  • Royce & Associates opened 62 new positions and closed 68 in Q3 2022.
  • Royce & Associates's portfolio value fell 9% quarter-over-quarter to $8.84B.

Based on Royce & Associates's 13F filing for Q3 2022, filed 3 Nov 2022.